One Time Rise: NPPA approves 50 percent price hike for Carbamazepine, Ranitidine, Ibuprofen Medical Dialogues Team3 July 2021 10:55 AM ISTNew Delhi: Through a recent gazette notification, the National Pharmaceutical Pricing Authority (NPPA) has allowed a one-time hike of 50 per cent in...
WHO releases list of priority medical devices for diabetes, cardiovascular diseases management, Details Medical Dialogues Team2 July 2021 5:48 PM ISTNew Delhi: In order to aid policymakers and health-care providers in prioritizing the selection and procurement of medical devices for cardiovascular...
Dr Reddys fails to secure CDSCO panel nod for Phase 3 trials of Sputnik Light Medical Dialogues Team2 July 2021 2:00 PM ISTNew Delhi: Denying permission to conduct phase-3 trials on the Russian vaccine Sputnik Light in India, the Subject Expert Committee (SEC) functional...
Novartis moves court against Roche seeking Rs 1565 crore overpaid amount in patent licensing pact Medical Dialogues Team1 July 2021 5:23 PM ISTNew Delhi: Accusing Roche of illegally pocketing fee from a 16-year-old patent licensing contract, Novartis has filed a lawsuit in U.S. District Court...
Setback to Bharat Biotech: Brazil suspends Covaxin order over graft allegations Medical Dialogues Team1 July 2021 1:30 PM ISTHyderabad: The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotechs Covid-19 vaccine Covaxin, on Wednesday announced...
MSD in talks with 5 Indian drugmakers for clinical trial of COVID drug Molnupiravir Medical Dialogues Team30 Jun 2021 5:28 PM ISTNew Delhi: MSD Pharmaceuticals, the wholly owned subsidiary of Merck Sharp Dohme, known as Merck & Co in the US, announced that it has decided to...
NPPA alleges overcharging for cancer drug Tagrisso: AstraZeneca moves Delhi HC against Rs 157 crore demand notice Medical Dialogues Team30 Jun 2021 5:02 PM ISTNew Delhi: AstraZeneca Pharma India has moved the Delhi High Court challenging a demand notice issued by the National Pharmaceutical Pricing Authority...
DoP directs NPPA to fix price of Darunavir, Ritonavir for Emcure Pharma Medical Dialogues Team29 Jun 2021 5:09 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), has recently directed the National Pharmaceuticals Pricing Authority (NPPA) to fix the retail...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
IPCA Lab gets CDSCO panel nod for phase 3 trial of HCQ as add-on therapy in type 2 diabetes Medical Dialogues Team27 Jun 2021 11:30 AM ISTNew Delhi: IPCA Laboratories has secured the Central Drugs Standard Control Organization (CDSCO) panel nod to conduct a Phase III clinical trial of...
NPPA panel fixes price of Intas Pharma oncology drug, Details Medical Dialogues Team27 Jun 2021 10:15 AM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of an oncology drug combination pack of...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Mankind Pharma Medical Dialogues Team25 Jun 2021 5:22 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, Dapagliflozin to consumers, the National Pharmaceutical Pricing...
